Lee Hartner, MD

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Radnor
View 1 additional location
Make an appointmentCall 610-902-5950
Penn Medicine Provider

About me

  • Director, GI-CREP Program
  • Clinical Director, Sarcoma Medical Oncology, Pennsylvania Hospital
  • Clinical Professor of Medicine (Hematology-Oncology)

My education and training

  • Medical School: Tufts University School of Medicine
  • Residency: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: Tufts - New England Medical Center

Spoken languages

English
English

Reviews

Average Rating

1607 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
i am very fortunate to have dr. hartner as my oncologist
Anonymous
May 2026
everything was perfect. nothing else to say.
Anonymous
May 2026
dr. hartner was kindly willing to send a voice message regarding my lab results ; as i prefer this delivery method for lab results .
Anonymous
May 2026
pleasant and professional attitude

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Hartner is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Chugh R et al THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 COMBINED WITH CHEMOTHERAPY IN EWING SARCOMA: PRELIMINARY DATA FROM A PHASE 1 STUDY , CTOS Annual Meeting: 2023

Van Tine B et al. RANDOMIZED PHASE II TRIAL OF CABOZANTINIB COMBINED WITH PD-1 AND CTLA-4 INHIBITION VERSUS CABOZANTINIB IN METASTATIC SOFT TISSUE SARCOMA. , CTOS Annual Meeting: 2023

Gounder M et al. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. , New England Journal of Medcine, 388(10): 2023,898-921

Gounder MM, Razak AA, Somaiah N, et al. Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. , J Clin Oncol., 40(22): 2022,2479-2490

Jia H, Roberson D, Luo X, Kovell RC, Hartner L, Harryhill JF. Primary follicular lymphoma of the prostate presenting with elevated PSA and a PI-RADS 3 lesion on MRI: A case report. , Urol Case Rep.: 2022

Brody RM, Shimunov D, Cohen RB, et al. A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers. , Oral Oncol.: 2022

Civantos AM, Prasad A, Carey RM, Bur AM, Mady LJ, Brody RM, Rajasekaran K, Cannady SB, Hartner L, Ibrahim SA, Newman JG, Brant JA. Palliative care in metastatic head and neck cancer , Head Neck, 43(9): 2021,2764-2777

Reddy VK, Jain V, Wilson Ii RJ, Hartner LP, Diamond M, Sebro RA, Weber KL, Maki RG, Shabason JE. Adult Pleomorphic Rhabdomyosarcomas: Assessing Outcomes Associated with Radiotherapy and Chemotherapy Use in the National Cancer Database , Sarcoma, 2021: 2021,9712070

Baumann BC, Bernstein KA, DeLaney TF, Simone CB 2nd, Kolker JD, Choy E, Levin WP, Weber KL, Muniappan A, Berman AT, Staddon A, Hartner L, Van Tine B, Hirbe A, Glatstein E, Hahn SM, Nagda SN, Chen YL. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity , J Surg Oncol, 122(5): 2020,877-883

Chow W, Frankel P, Ruel C, Araujo DM, Milhem M, Okuno S, Hartner L, Undevia S, Staddon A. Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma , Cancer, 126(1): 2020,105-111